The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders

American Journal on Addictions

Volumn 16, Issue 6, 2007, Pages 443-449

  Ralevski, Elizabeth ^a,b   Ball, Samuel ^a   Nich, Charla ^a   Limoncelli, Diana ^a   Petrakis, Ismene ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIRAM; NALTREXONE; PLACEBO;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANTISOCIAL BEHAVIOR; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PERSONALITY DISORDER; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; ANTISOCIAL PERSONALITY DISORDER; BEHAVIOR, ADDICTIVE; BORDERLINE PERSONALITY DISORDER; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISULFIRAM; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT COMPLIANCE; PERSONALITY DISORDERS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 36849061583     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490701643336     Document Type: Article

References (31)

1. National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA). Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation. Bethesda, Md.: National Institutes of Health; 1989.
2. Regier DA, Farmer ME, Rae DS. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) study. JAMA. 1990;264:2511-2518.
3. Ross H, Glaser F, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1988;45:1023-1031.
4. Skodol AE, Oldham JM, Gallaher PE. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders. Am J Psychiatry. 1999;156:733-738.
5. Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 2004;74:223-234.
6. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35:1747-1759.
7. Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005;80:105-116.
8. Merikangas K, Stevens D. Models of transmission of substance use and comorbid psychiatric disorders. In: Kranzler H, Rounsaville B, eds. Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders. New York: Marcel Dekker;1998:31-53.
9. Meyer R. How to understand the relationship between psychopathology and addictive disorders: nother example of the chicken and the egg. In: Meyer R, ed. Psychopathology and Addictive Disorders. New York: Guilford Press;1986:3-16.
10. Carroll KM, Ball SA, Rounsaville BJ. A comparison of alternate systems for diagnosing antisocial personality disorder in cocaine abusers. J Nerv Ment Dis. 1993;181:436-443.
11. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2005;66:677-685.
12. Rounsaville B, Kleber H. Psychiatric disorders in opiate addicts: preliminary findings on the course and interaction with program type. In: Meyer R, ed. Psychopharmacology and Addictive Disorders. New York: Guilford Press;1986:14-168.
13. Schuckit MA. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry. 1985;42:1043-1049.
14. Verheul R, van den Bosch L, Ball S. Substance abuse. In: Oldham JM, Skodol AE, Bender DS, eds. Textbook of Personality Disorders. Washington, DC: American Psychiatric Publishing; 2005:463-476.
15. Pettinati HM, Pierce Jr JD, Belden PP, Meyers K. The relationship of Axis II personality disorders to other known predictors of addiction treatment outcome. Am J Addict. 1999;8:136-147.
16. Stepp SD, Trull TJ, Sher KJ. Borderline personality features predict alcohol use problems. J Personal Disord. 2005;19:711-722.
17. Cacciola JSP, Alterman AIP, McKay JRP, Rutherford MJP. Psychiatric comorbidity in patients with substance use disorders: do not forget Axis II disorders. Psychiatric Annals. 2001;31:321-331.
18. Morgenstern J, Langenbucher J, Labouvie E, Miller KJ. The comorbidity of alcoholism and personality disorders in a clinical population: prevalence rates and relation to alcohol typology variables. J Abnorm Psychol. 1997;106:74-84.
19. Tomasson K, Vaglum P. Antisocial addicts: the importance of additional axis I disorders for the 28-month outcome. Eur Psychiatry. 2000;15:443-449.
20. Combine Study Research Group. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcohol Clin Exp Res. 2003;27:1107-1122.
21. Petrakis IL, Poling J, Levinson C, Nich C, Rounsaville B. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry. 2005;57:1128-1137.
22. First MD, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (patient ed.). New York: Biometric Research, New York State Psychiatric Institute; 1996.
23. First M, Spitzer R, Gibbon M, Williams JB, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (Ver. 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1996.
24. Carroll KM, Nich C, Ball SA, McCance E, Rounsaville BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93:713-727.
25. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten RZ, Allen J, eds. Measuring Alcohol Consumption: Psychosoical and Biological Methods. Totowa, NJ: Humana Press;1992:41-72.
26. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 1996;53:225-231 [published erratum appears in Arch Gen Psychiatry. 1996 Jul;53(7):576].
27. Skinner HA, Horn JL. Alcohol Dependence Scale (ADS): User's Guide. Toronto: Addiction Research Foundation; 1984.
28. Dawson DA, Grant BF, Stinson FS, Chou PS, Huang B, Ruan WJ. Recovery from DSM-IV alcohol dependence: United States, 2001-2002. Addiction. 2005;100:281-292.
29. Tiffany ST, Conklin CA. A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction. 2000;95 Suppl 2:S145-153.
30. Verheul R, Kranzler HR, Poling J, Tennen H, Ball S, Rounsaville BJ. Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact? J Stud Alcohol. 2000;61:101-110.
31. Zanarini MC, Frankenburg FR, Dubo ED, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;155:1733-1739.